NEW YORK (GenomeWeb News) – Myriad Genetics reported after the close of the market Tuesday that revenues for its fiscal fourth quarter rose 24 percent year over year, beating the consensus Wall Street estimate.

The company also reported that revenues for full-year fiscal 2012 increased 23 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.